Cell BioEngines, Inc.
PrivateLast Round
Seed
Jul 20, 2024
Total Funding Raised
$2.53M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Cell BioEngines, Inc. is a biotechnology company that develops allogeneic 'off-the-shelf' stem cell and its derived therapies for human disease treatment, with a focus on oncology and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cell BioEngines, Inc. Comparables
Compare Cell BioEngines, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stratus Therapeutics | 88% | |
| Artiva | 74% | |
| Gamida Cell Ltd. | 73% |
Cell BioEngines, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 20, 2024 | ||||
| Accelerator | Sep 13, 2023 |
Key People
Founding team and executive leadership
Cell BioEngines, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Empire State Development | Seed |
| Partnership for New York City | Seed |
| IndieBio | Accelerator |
| SOSV | Accelerator, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 183% MoM, reaching 3.1K.
- Jun 18, 2026
Monthly visitors increased 68% MoM.
Cell BioEngines, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cell BioEngines, Inc.'s valuation, stock price, and market status.
Is Cell BioEngines, Inc. a public or private company?
Cell BioEngines, Inc. is a private company.
What is the current stock price of Cell BioEngines, Inc.?
Cell BioEngines, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Cell BioEngines, Inc. worth (valuation)?
Valuation information for Cell BioEngines, Inc. is not publicly available.
Can I buy Cell BioEngines, Inc. stock?
Cell BioEngines, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cell BioEngines, Inc.'s last funding round?
Cell BioEngines, Inc.'s most recent funding round was Seed on July 20, 2024.
Who are the main investors in Cell BioEngines, Inc.?
Key investors in Cell BioEngines, Inc. include Empire State Development, IndieBio, SOSV.
Will Cell BioEngines, Inc. IPO soon?
No public IPO plans have been announced for Cell BioEngines, Inc..
How can I track Cell BioEngines, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cell BioEngines, Inc.'s secondary market activity and sign up for updates.